Bioventus (BVS) - 2025 Q4 - Earnings Call Transcript
Bioventus (NasdaqGS:BVS) Q4 2025 Earnings call March 05, 2026 08:30 AM ET Company ParticipantsCaitlin Cronin - Director - MedTech Equity ResearchDave Crawford - VP of Investor Relations and TreasurerMark Singleton - SVP and CFORob Claypoole - President and CEOConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMichael Petusky - Research AnalystRob ClaypooleGood day, and welcome to the Bioventus Q4 2025 earnings conference call. All participants will be in a listen-only mode. Should you ...